Results 171 to 180 of about 23,280 (257)

Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients

Patient Preference and Adherence, 2015
Qiang Du, Yan-Jun Wang, Sheng Yang, Ping HanDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of ChinaAbstract: The prevalence of diabetes mellitus (DM) continues to increase each ...
Du Q, Wang YJ, Yang S, Han P
doaj  

Cost-Effectiveness Analysis of Triple Oral Antidiabetic Drug Combination in Patients With Type 2 Diabetes Mellitus: An Outpatient Study in Indonesia. [PDF]

J ASEAN Fed Endocr Soc
Hanifiyah IA, Nita Y, Libriansyah, Ridwan A, Achmad GNV.   +4 more
europepmc   +1 more source

Discovery and evolution of an (<i>R</i>)-selective transaminase for production of sitagliptin. [PDF]

RSC Chem Biol
Treadell M, Surman GRE, Ford GJ, Otun CW, Srinivasan SJ, Galman J, Bawn M, Pandya A, Markin CJ, Green AP, Rowbotham JS.   +10 more
europepmc   +1 more source

High-affinity inclusion of sitagliptin by cucurbit[7]uril: structural insights and fluorescence-based sensing. [PDF]

RSC Adv
Al-Joumhawy MK, Assaf KI, Alnajjar MA, Sukkar RZ, Rawashdeh AMM.   +4 more
europepmc   +1 more source

Sitagliptin to Patients With Postprandial Hypotension Without Diabetes. [PDF]

Geriatr Gerontol Int
Ishikawa J, Toba A, Harada K.
europepmc   +1 more source

Cost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk. [PDF]

Front Public Health
Lai L, Chuan F, Huang Q, Xiong N, Peng C, Zhao R, Sun J, Liu Q, Lu J.   +8 more
europepmc   +1 more source

Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes: An emulated target trial. [PDF]

Medicine (Baltimore)
Kim TH, Hwang Y, Woo S, Lee K, Son Y, Park S, Kim H, Shin JY, Cho Y, Shin D, Cho D, Lee KJ, Kim CH, Rhee SY, Yon DK.   +14 more
europepmc   +1 more source

First-derivative synchronous spectrofluorimetric method for simultaneous determination of dapagliflozin and sitagliptin in dosage forms and spiked human plasma. [PDF]

Sci Rep
El-Dosoky MA, El-Desouky EA, Abdelzaher AM, Hasan MA, Mahdy MA.   +4 more
europepmc   +1 more source

Dipeptidyl peptidase-4 inhibitors suppress myofibroblastic differentiation and hyaluronan synthesis in Graves' orbitopathy fibroblasts. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Tsai FC, Shih SR, Liao SL, Chu I, Hong TM, Liao NL, Wei YH.   +7 more
europepmc   +1 more source

Comparison of the permeability of DPP-4 inhibitors-sitagliptin, vildagliptin, linagliptin, and alogliptin-in placental barrier cell models and exploration of their transport mechanisms by LC-MS/MS. [PDF]

BMC Pregnancy Childbirth
Bai M, Shen Q, Wu Y, Chen M, Liu D, Lin N, Zhang W.   +6 more
europepmc   +1 more source